Author Archive

From Misdiagnosis to Remission

http://  Approx. 43 Min

Aug 5, 2025 DrTalks Podcast
Hear Jennifer Crystal share her inspiring journey of resilience and recovery from chronic Lyme disease in conversation with Dr. Richard Horowitz. Jennifer Crystal opens up about her long journey with Lyme disease, from years of being misdiagnosed and dismissed to finally finding the right treatment. She shares the challenges of living with chronic illness, the role of resilience and support, and the lessons she hopes will inspire others facing similar struggles.
Jennifer Crystal is the author of One Tick Stopped the Clock, a powerful memoir chronicling her journey with Lyme disease. After years of misdiagnoses, she found answers and healing through proper treatment and resilience. Today, Jennifer advocates for greater awareness of tick-borne illnesses, sharing her story to inspire patients and educate caregivers and physicians alike. She has also worked with the Harvard Lyme Wellness Initiative.
For more:

FDA Belatedly Admits Ivermectin Works for COVID But Red Cross Suppresses Malaria Cure Since 2012

https://www.2ndsmartestguyintheworld.com/p/breaking-fda-finally-admits-ivermectin?

BREAKING: FDA Finally Admits Ivermectin Works — After Years of Calling It ‘Horse Paste’ 🚨

Readers of this Substack appreciate just how murderously corrupt the FDA is, and how Ivermectin is a miracle compound…

PetMectin: Pharmaceutical Grade Pure Ivermectin

PetMectin: Pharmaceutical Grade Pure Ivermectin

Ivermectin is perhaps the single best treatment not just for PSYOP-19, but for the spike protein damage that is induced by the slow kill bioweapon injections.  Read full story

…but now, under MAHA leadership, it appears that the FDA is finally backing down on its war against Ivermectin, with journalist Maria Bartiromo stating matter of factly:

The FDA is now saying that it’s okay to take ivermectin if you have COVID.

The following clip is currently trending on X:

🚨 BREAKING: FDA Finally Admits Ivermectin Works — After Years of Calling It ‘Horse Paste’

🚨 For YEARS, Americans were mocked, censored, and silenced for even mentioning Ivermectin — branded as nothing but “horse paste.” Doctors risked their licenses, patients were denied care, and the media ran cover for Big Pharma.

Now the FDA quietly admits: Ivermectin is fine to treat COVID.

👉 A cheap, Nobel Prize-winning medicine smeared to protect profits.

👉 Hundreds of thousands may have died needlessly while “experts” pushed endless boosters.

👉 Families were left in the dark — while the truth was ridiculed and suppressed.

The FDA has blood on its hands. Lives were lost. Trust was shattered. All for politics and profit. America deserves answers. America deserves accountability.

Source

Imagine if you will during the PSYOP-19 scamdemic that Ivermectin administration was widely adopted, and that all of a sudden cases of cancer, Alzheimer’smood disorders, even Parkinson’s started plummeting (alongside BigPharma profits)?  (See link for article and video)

_______________

https://pierrekorymedicalmusings.com/p/the-red-cross-suppressed-a-cure-for?

The Red Cross Suppressed A Cure For Malaria in 2012, Causing Over Half A Million People To Die Every Year Since

More evidence that international health care organizations (and all governmental health care and regulatory agencies) are fully captured by Big Pharma.

I am going to start this post out with my standard declaration that: 1) I am not suicidal, 2) I am in good health, and 3) I am living my best life. For what that is worth.

The Red Cross Malaria Trial

“The Water Reference Center (WRC)” is a research center within the International Federation of Red Cross and Red Crescent Societies (IFRC). In 2012, their CEO at the time, Klaas Proesmans, conducted a study testing the efficacy of a common water purification agent called chlorine dioxide to treat malaria. The treatment consisted of increasing the concentration in cups of drinking water to levels above those typically used solely for water purification. Note that this effective treatment was first accidentally discovered by an applied scientist working in Nigeria in 1982, as I reported in this prior post.

In that study, the WRC and the Ugandan Red Cross identified 154 patients from the community around Iganga, Uganda, using skin pricks to gather drops of blood from patients suspected of being ill with malaria. They then placed the blood on slides and examined them under a microscope to look for the malaria parasite. Then they treated the patients who were positive for malaria by giving them cups of water to drink that had been treated with chlorine dioxide in the form of what Jim Humble called “Master Mineral Solution” (a mixture of sodium chlorite and hydrochloric acid). They then had the patients return to the testing/study center daily for re-testing and clinical follow-up.

They rapidly cured 154 malaria patients within two days. Sounds historic, right? A cure for malaria had been found! But no, it was not to be. Not even close.

As word of the trial and its success began to circulate, the “authorities” sprang into action, culminating in the Ugandan Red Cross and the International Federation of Red Cross and Red Crescent Societies (IFRC) issuing statements denying any official involvement in the study. They then went even further, stating that no formal clinical trial or endorsement of MMS took place under their auspices. The IFRC also added that “chlorine dioxide is not approved for the treatment of malaria and that any suggestion of Red Cross involvement was misleading.” They even got the CEO of the Water Reference Center who had planned and conducted the trial… to deny it ever happened.

Interestingly, none of the statements above were published in an official Press Release or statement; they were instead communicated solely via quotes in an interview with an investigative journalist in a blatantly obvious “debunking article” published by Business Insider.

First, I will review the extensive evidence verifying both the conduct and results of that trial. Then I will cover the above “Disinformation Response” from the media and the Red Cross in more detail. However, to understand the importance of the documented evidence that I will provide below, you need to know that the Business Insider article tried to “debunk” the claim that the trial was done by: 1) claiming it never took place, and 2) that Red Cross officials were “duped” into taking part. Yes, I know, the argument contradicts itself – either the trial never took place or Red Cross officials were “duped” into taking part, you can’t have both. Later, you will see how they later reconciled those two statements.  (See link for article and documentation and results of the trial)

____________

**Comment**

For those of you who are late to the party, know this: government ‘health agencies’ are not about health at all and have covered up and lied and continue to lie about effective, safe, cheap treatments for decades.  Further, they are riddled with conflicts of interest and are in bed with Big Pharma.

Both ivermectin and chlorine dioxide have cured people of innumerable diseases.

For more:

Ivermectin:

Chlorine Dioxide (MMS, MMS1, CDS)

DMSO: Unlocking Pain Relief, Healing, Cancer & More

I’m a big believer in silver linings and in counting your blessings.  COVID, horrific as it was, unlocked many silver linings: it’s easier for people to work from home, many have discovered homeschooling isn’t so difficult after all, the rise of telehealth, many have now discovered that science has been hijacked and that it’s more important than ever to ‘believe but verify,’ and of course the plethora of life-changing information on home remedies such as chlorine dioxide and DMSO.  The following article is one such example.

https://onedaymd.substack.com/p/dmso-unlocking-pain-relief-healing?

DMSO: Unlocking Pain Relief, Healing, Cancer, and More (2025)

In This Article:

  1. Introduction
  2. What is DMSO
  3. DMSO and Cancer
  4. DMSO and Tissue Healing
  5. DMSO and Musculoskeletal Injuries
  6. DMSO and Sports Injuries
  7. DMSO’s Diverse Benefits (Summary)
  8. DMSO Dosage in Humans
  9. DMSO Side Effects and Safety
  10. Find DMSO Providers
  11. Conclusion

Introduction

In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. (1)

“I decided that I will make that decision,” she said, “only if it’s the last resort, and I’m on my deathbed.”

A few months before her consultation, however, Eyres, then fifty-eight, made an appointment with a new primary care doctor for routine prescription refills. She was about to be introduced, literally and figuratively, to a new kind of medicine. It would change everything.

Dr. James Miller, a former surgeon, liked to get to know his patients, so he asked Eyres for her history. She told him of her diagnosis, thirty years prior, with a serious but manageable case of scleroderma. In 2020, however, this auto-immune disorder, which can affect skin and organs, showed exactly what it could do.

Exhausted and tethered to an oxygen tank, Eyres spent months on her couch. She took medications that had awful side effects. Her lungs were “loaded with ground glass opacities in the lower lobes,” she said, which CT scans confirm. Eyres was diagnosed in 2021 with interstitial lung disease and pulmonary arterial hypertension. Her work in physical fitness was over.

When Eyres finished her history, she got two surprises. Miller agreed it was likely that the covid shots had made her condition, he later told me, “massively worse.” He then listened to her lungs to see how bad they sounded. “Don’t rush that,” he said of the transplant, a sure sign of a doctor who believed in other options.

Eyres was ecstatic. Miller, she said, was the “first doctor that actually hears me.” Miller then offered Eyres help in the form of three easy-to-find supplements for her vaccine injury: nattokinase, bromelain, and turmeric. She soon felt better.

It was on her second visit, a month later, that Miller suggested Eyres smear a gel supplement over her chest and lung area called DMSO to help her condition. This time, Eyres “kinda gave the eye roll,” she told me.

She was in for the biggest surprise yet.

Erica’s Turning Point

In December 2023, seven months before she saw Dr. Miller, Eyres’ second CT scan results were again ominous. They read in part, “Re-demonstrated diffuse centrilobular ground glass nodularity in the lungs, slightly more pronounced in the lower lobes … Expiratory images demonstrate air trapping throughout both lungs.” (Ground glass nodules, common in late-stage covid, are abnormal spots on the lungs. Air trapping is the inability to fully exhale, leading to shortness of breath.)

The diagnosis was given as interstitial lung disease or ILD.

In November 2024, Eyres went for another CT scan in preparation for a lung transplant consultation. She had been using DMSO for five months at that point, mostly topically and in the previous month, orally. The scan found, “No evidence of interstitial lung disease. No air-trapping.”

The subsequent transplant consultation was swift: The pulmonologist looked at her CT results and told her she was stable, she said. “Nothing more we need to do,” he said.

“We head over to the transplant center and the doctor comes in and sits down and tells me, ‘You do not have ILD, your lungs on CT scan are clear!!!!’” Eyres wrote in an email to me.

“Nobody can understand or explain this,” she wrote. “All I can say is, where did the ground glass go? It was there and now it’s not. DMSO.”

She had made her appointment with Miller only because her standing primary care doctor was not available. “BEST thing I ever did!!!!” she wrote. (1)  (See link for article)

_______________

**Comment**

‘Must read’ article.  It exemplifies how DMSO can do so many things and no Lyme/MSIDS patient should be without it.

Readers of this website know about DMSO, how it works, and the many things it helps, but I love the testimonials of successful usage as well as the list of DMSO doctors.

For more:

MAHA Report Addresses EMFs & Study Shows High Wireless EMF Exposure More Than Triples Risk of Neuro Delays in Infants

https://prod.cdn.everyaction.com

Environmental Health Trust is a 501(c)(3) non-profit organization.

We depend on generous donations from our community.  

Join Our Newsletter | Healthy Tech at Home Project | Wildlife and Wireless

https://www.thefocalpoints.com/p/new-study-high-wireless-emf-exposure?

NEW STUDY: High Wireless EMF Exposure More Than Triples Risk of Neurodevelopmental Delays in Infants

First-ever infant cohort study using direct home RF-EMF measurements finds major increases in motor, problem-solving, and social deficits — even at everyday Wi-Fi and cell tower levels.

A major new study titled, Radiofrequency Electromagnetic Field Emissions and Neurodevelopmental Outcomes in Infants: A Prospective Cohort Studyhas delivered one of the clearest warnings yet about the effects of everyday wireless radiation on babies.

Unlike past research based on phone-use surveys, this team directly measured radiofrequency electromagnetic fields (RF-EMF) inside homes — from sources like cell towers, Wi-Fi routers, cordless phones, and Bluetooth devices — and tracked real brain and motor development in infants over their first year.

The result? Higher in-home radiation was strongly linked to delays in fine motor skills, problem-solving ability, and social development — even after accounting for birth weight, maternal age, and income level.

What They Measured

Scientists went into homes with a professional spectrum analyzer, measuring total RF-EMF from all sources in the living environment — not just cell towers.

This included:

  • Wi-Fi routers (often running 24/7)

  • Cordless phones and their base stations

  • Bluetooth devices like speakers, earbuds, and baby monitors

  • Nearby cell towers

  • Smart TVs, tablets, and smart home hubs

(See link for article & video)

_______________

**Comment**

The study showed that everyday wireless radiation in the home at levels most would consider ‘normal’ may harm brain development with babies as they faced nearly 2-4 times the odds of developmental delays.

For more:

LymeSeek Test Promises Earlier, More Accurate Diagnosis

https://danielcameronmd.com/lymeseek-lyme-blood-test/

New Lyme Blood Test Outperforms Standard Testing

Lyme Science Blog

Aug26

New Lyme Blood Test LymeSeek Promises Earlier, More Accurate Diagnosis

Lyme disease is one of the few infections where patients are often diagnosed too late — not because they waited, but because testing could not detect the infection until later stages – if at all.

A new Lyme blood test called LymeSeek could change that. It aims to revolutionize Lyme diagnostics by delivering significantly higher accuracy, especially in early disease detection — where current tests often fall short.

Holly Ahern, MS, MT, Chief Scientific Officer at Aces Diagnostics, discusses LymeSeek. For more information, visit https://www.acesdiagnostics.com/lymeseek

According to data presented at the 2025 Association for Diagnostics and Laboratory Medicine meeting, LymeSeek demonstrated over 90% sensitivity and specificity in detecting Lyme disease across all phases of illness — from early localized to post-treatment.

That’s a significant improvement over standard two-tier testing, which often misses early cases when treatment matters most. Reliable testing is particularly important since an estimated 30% of patients never develop the classic bull’s-eye rash, which most practitioners rely on for diagnosing the disease.


Why Current Lyme Testing Often Fails

Current Lyme disease tests miss many infections — especially early ones — mainly because of how they work and what they’re looking for.

They don’t detect the bacteria itself

  • Most current tests (like the CDC-recommended two-tier testing) look for antibodies your immune system makes against Borrelia burgdorferi. However, it can take several days to weeks for antibodies to develop. That means serologic testing can produce false negatives — especially in the first 2–4 weeks after infection. This is one of the biggest frustrations for providers treating patients in Lyme endemic areas. Many patients never test positive

The CDC’s recommended two-tier system is rigid and outdated

  • Patients are initially given an ELISA test. If positive or equivocal, they then receive the Western blot. If either of these test results are negative, the patient supposedly doesn’t have Lyme disease – even when they might.

  • This system was designed decades ago mainly for surveillance, not for highly sensitive early diagnosis.

Borrelia’s biology makes testing tricky

  • The bacteria changes the proteins it expresses at different stages of infection, meaning antibody targets aren’t consistent.

  • It can hide in tissues and reduce exposure to the immune system (immune evasion), which delays or blunts antibody production.

Strain and species variation

  • U.S. tests focus mainly on B. burgdorferi sensu stricto. If someone is infected with another species like: B. mayoniiB. garinii, or B. afzelii, testing may not detect those antigens, leading to a false negative result.

Past infection vs. active infection confusion

  • Once antibodies form, they can persist for months to years after treatment. Therefore, testing cannot distinguish whether an infection is newongoing, or old. A patient may have an old infection that has resolved and doesn’t require treatment.

What Makes This New Lyme Blood Test Different?

The new Lyme blood test uses a multiplexed antigen assay—testing for 10 different immune responses at once. Then, a machine learning algorithm interprets the results. This approach improves both sensitivity and specificity, especially in early disease when antibodies are still forming.

In head-to-head comparison:

  1. In early disease (0–72 hours after EM rash), LymeSeek detected 100% of cases vs. just 37% with standard testing.

  2. In post-treatment Lyme (6+ months after infection), LymeSeek identified 97% of cases vs. 46% with standard tests.

That means better detection without waiting for seroconversion, and better confirmation of past infection when patients present with persistent symptoms.


Will This Test Change Lyme Disease Care?

It could—eventually.

This new Lyme blood test may help:

  1. Identify early Lyme before antibodies form

  2. Confirm cases when no rash is present

  3. Support diagnosis in patients with ongoing symptoms after treatment


Is the New Lyme Blood Test Available Now?

🚫 It is not yet FDA-approved or available for patient ordering through clinics or commercial labs.

ACES Diagnostics is currently working with the FDA on clinical trial pathways. The test has received a De Novo classification, meaning it’s being evaluated as a novel diagnostic tool—not just compared to current testing.

If approved, LymeSeek could be a game-changer for early Lyme detection and for patients with post-treatment symptoms who need better answers.


Final Thoughts

A new test can’t fix every challenge that comes with Lyme disease. But it could mean getting answers sooner, missing fewer cases, and giving doctors more confidence in diagnosing.


Links

  1. Clinical Testing and Diagnosis for Lyme Disease

  2. LymeSeek: Blood test with 90% accuracy

  3. Why I Treat Babesia Even if the Tests Are Negative